SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

NEM Newmont Corporation

Basic Materials · Gold · website · 17,500 employees
$165.52
52wk 117.58 – 190.91
Overall
82.2
Value
60.0
Growth
96.5
Health
100.0
Quality
100.0
Momentum
59.7
Dividend
69.6
Price
About Newmont Corporation

Newmont Corporation operates as a gold producer. It also explores for copper, silver, lead, zinc, and other metals. It has operations and/or assets in the United States, Papua New Guinea, Australia, Ghana, Suriname, Argentina, Dominican Republic, Chile, Peru, Ecuador, Mexico, and Canada. The company was founded in 1916 and is headquartered in Denver, Colorado.

Commodity exposure

Primary exposure: Gold (detected from the company profile: gold)

Gold primary
4,213.80 USD/oz
1m: -3.5% · 1y: 9.7%
Copper
6.58 USD/lb
1m: 1.3% · 1y: 34.4%
Silver
61.52 USD/oz
1m: -4.9% · 1y: 33.7%
Zinc
No direct price series on Yahoo Finance
Price analytics

Returns

1 day -0.2%
1 week -3.2%
1 month -5.4%
3 months 20.3%
6 months -3.5%
1 year 24.2%
3 years —

Risk

Volatility (1y ann.) 48.0%
Beta vs ASX 200 2.09
Sharpe (1y) 0.61
VaR 95% (1-day) -4.9%
Max drawdown (1y) -31.8%
Off 1-year high -12.2%

Technicals

RSI(14) 37
vs 50DMA -0.3%
vs 200DMA 4.5%
Trend Golden cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 60.0
Trailing P/E
79
Forward P/E
88
PEG ratio
15
EV / EBITDA
62
Price / Book
63
Price / Sales
35
Growth 96.5
Revenue growth (1y)
90
Revenue CAGR (3y)
100
EPS growth (1y)
100
EPS CAGR (3y)
—
Financial Health 100.0
Net debt / EBITDA
100
Interest coverage (EBIT/interest)
100
Current ratio
100
Debt / Equity
100
Quality (Profitability & Cash Flow) 100.0
Return on equity
100
Return on assets
100
Operating margin
100
Net margin
100
Cash conversion (OCF / net income)
100
Dividend / Income 69.6
Dividend yield (%)
15
Payout ratio
100
FCF dividend cover
100
Momentum 59.7
6-month return vs ASX 200
59
Price vs 200-day average
65
Price vs 50-day average
48
Position in 52-week range
65

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$174.41B
P/E (trailing)
14.49
P/E (forward)
11.29
EPS (trailing)
11.42
Dividend yield
0.9%
Payout ratio
12.9%
Beta
0.54
EV / EBITDA
10.03
Price / Book
3.45
ROE
25.9%
Operating margin
51.6%
Net margin
33.4%
Total cash
$9.01B
Total debt
$5.60B
Current ratio
2.55
Debt / Equity
0.16
Free cash flow
$8.82B
Avg volume
332,867
Latest annual results (FY ending 31 Dec 2025)
  • Revenue$22.67B
  • Gross profit$12.06B
  • Operating income$11.02B
  • Net income$7.08B
  • Diluted EPS6.39
  • Free cash flow$7.30B
  • Net debt-$2.06B
Sector peers (Basic Materials)
TickerMkt cap P/EScore
BHP $311.13B 22.0 68.1
RIO $268.04B 15.5 58.1
FMG $49.85B 12.1 60.7
NST $34.22B 20.7 76.0
EVN $26.76B 17.9 79.4
S32 $22.08B 14.5 67.1
JHX $20.94B 112.7 45.6
AAI $15.93B 8.8 62.6